123 related articles for article (PubMed ID: 10845676)
1. Iron, friend or foe? "Freedom" makes the difference.
Pietrangelo A
J Hepatol; 2000 May; 32(5):862-4. PubMed ID: 10845676
[No Abstract] [Full Text] [Related]
2. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma.
Marrogi AJ; Khan MA; van Gijssel HE; Welsh JA; Rahim H; Demetris AJ; Kowdley KV; Hussain SP; Nair J; Bartsch H; Okby N; Poirier MC; Ishak KG; Harris CC
J Natl Cancer Inst; 2001 Nov; 93(21):1652-5. PubMed ID: 11698570
[No Abstract] [Full Text] [Related]
3. YAP in tumorigenesis: Friend or foe?
Liu S; Pang Q; Zhang J; Liu C
J Hepatol; 2015 Jun; 62(6):1444. PubMed ID: 25687424
[No Abstract] [Full Text] [Related]
4. Reply to: "YAP in tumorigenesis: Friend or foe?".
Perra A; Kowalik MA; Giordano S; Columbano A
J Hepatol; 2015 Jun; 62(6):1445. PubMed ID: 25701465
[No Abstract] [Full Text] [Related]
5. Iron and hepatocellular carcinoma.
Deugnier Y; Turlin B
J Gastroenterol Hepatol; 2001 May; 16(5):491-4. PubMed ID: 11350542
[TBL] [Abstract][Full Text] [Related]
6. Dietary iron overload in the African and hepatocellular carcinoma.
Kew MC; Asare GA
Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
[TBL] [Abstract][Full Text] [Related]
7. [Iron overload and cancer].
Blanc JF; Bioulac-Sage P; Balabaud C
Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
[TBL] [Abstract][Full Text] [Related]
8. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
9. Tumour promotion versus tumour suppression in chronic hepatic iron overload.
Bloomer SA; Brown KE
Cell Biochem Funct; 2015 Jun; 33(4):241-8. PubMed ID: 26059599
[TBL] [Abstract][Full Text] [Related]
10. A liver mass in an iron-overloaded thalassaemia intermedia patient.
Maakaron JE; Musallam KM; Ayache JB; Jabbour M; Tawil AN; Taher AT
Br J Haematol; 2013 Apr; 161(1):1. PubMed ID: 23294457
[No Abstract] [Full Text] [Related]
11. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
[TBL] [Abstract][Full Text] [Related]
12. Disease progression and liver cancer in the ferroportin disease.
Corradini E; Ferrara F; Pollicino T; Vegetti A; Abbati GL; Losi L; Raimondo G; Pietrangelo A
Gut; 2007 Jul; 56(7):1030-2. PubMed ID: 17566043
[No Abstract] [Full Text] [Related]
13. Iron overload and hematologic malignancies.
Franchini M; Veneri D
Hematol J; 2004; 5(5):381-3. PubMed ID: 15448663
[TBL] [Abstract][Full Text] [Related]
14. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
[TBL] [Abstract][Full Text] [Related]
15. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
16. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].
Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P
Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience.
Restivo Pantalone G; Renda D; Valenza F; D'Amato F; Vitrano A; Cassarà F; Rigano P; Di Salvo V; Giangreco A; Bevacqua E; Maggio A
Br J Haematol; 2010 Jul; 150(2):245-7. PubMed ID: 20433678
[No Abstract] [Full Text] [Related]
18. [From iron accumulation to organ damage].
Zaccone V; Gasbarrini G
Minerva Med; 2012 Apr; 103(2):123-40. PubMed ID: 22513517
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
Torres DM; Harrison SA
Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in the thalassaemia syndromes.
Borgna-Pignatti C; Vergine G; Lombardo T; Cappellini MD; Cianciulli P; Maggio A; Renda D; Lai ME; Mandas A; Forni G; Piga A; Bisconte MG
Br J Haematol; 2004 Jan; 124(1):114-7. PubMed ID: 14675416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
